EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Galactose-modified erythrocyte membrane fusion liposomes enable the targeted delivery of drug nanoparticles to the liver

Jiayu Song, Huanhuan Zhang, Xiaohui Zhang, Meiying Liu, Dan Peng, Yuan Ren, Yan Sun, Yunlan Li iD

RSC Advances · 2025 · 15 (22) · 17781-17794

DOI: 10.1039/d4ra07489k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Jiayu Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Shanxi Medical University Taiyuan 030001 P. R. China liyunlanrr@163.com +86 13111066649. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Shanxi Medical University, Shanxi Provincial Key Research and Development Project, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The safe and efficient delivery of chemicals and biologics remains crucial for liver disease therapy.

Autor:innen und Institutionen

  • School of Pharmaceutical Science, Shanxi Medical University Taiyuan 030001 P. R. China liyunlanrr@163.com +86 13111066649.
  • College of Medical Technology, Luohe Medical College Luohe 462000 P. R. China.
  • School of Public Health, Shaanxi University of Chinese Medicine Xi'an 712046 P. R. China.

ORCID-Profile: Yunlan Li

Förderung

  • Shanxi Medical University
  • Shanxi Provincial Key Research and Development Project
  • National Natural Science Foundation of China
  • Henan Provincial Science and Technology Research Project
  • Shaanxi Administration of Traditional Chinese Medicine

Zitieren

APA

Song, J., Zhang, H., Zhang, X., Liu, M., Peng, D., Ren, Y., Sun, Y., & Li, Y. (2025). Galactose-modified erythrocyte membrane fusion liposomes enable the targeted delivery of drug nanoparticles to the liver. RSC Advances, 15(22), 17781-17794. https://doi.org/10.1039/d4ra07489k

Vancouver

Song J, Zhang H, Zhang X, Liu M, Peng D, Ren Y, et al. Galactose-modified erythrocyte membrane fusion liposomes enable the targeted delivery of drug nanoparticles to the liver. RSC Advances. 2025;15(22):17781-17794. doi:10.1039/d4ra07489k

BibTeX
@article{Song2025,
  author = {Song, Jiayu and Zhang, Huanhuan and Zhang, Xiaohui and Liu, Meiying and Peng, Dan and Ren, Yuan and Sun, Yan and Li, Yunlan},
  title = {Galactose-modified erythrocyte membrane fusion liposomes enable the targeted delivery of drug nanoparticles to the liver},
  journal = {RSC Advances},
  year = {2025},
  volume = {15},
  number = {22},
  pages = {17781--17794},
  doi = {10.1039/d4ra07489k}
}
Kostenlos starten →